爱泌罗的用药指南和特殊人群用药

Almerol is suitable for relieving bladder pain or discomfort related to interstitial cystitis. The drug was developed by Johnson & Johnson in the United States and has been marketed in many foreign countries. However, it has not been approved for marketing in China, and it has not been included in the medical insurance list.

Amirol Indications

1. Indications

It is used to treat bladder pain or discomfort related to interstitial cystitis (IC).

2. Applicable population

Adult patients clinically diagnosed with interstitial cystitis and accompanied by bladder pain or discomfort.

Amirol Usage and Dosage

1. Recommended dosage

Take 300mg orally daily in three divided doses, one 100mg capsule each time.

2. How to take it

The capsule should be swallowed whole with water, at least 1 hour before or 2 hours after a meal, and avoid taking it with food at the same time.

3. Treatment evaluation

The efficacy will be fully evaluated again after 3 months of treatment. If the pain does not improve and no serious adverse events occur, continued treatment for 3 months may be considered.

For patients whose pain does not improve within 6 months, the clinical value and risks of continued treatment need to be re-evaluated.

The pictures come from public channels (such as the official website of the FDA, the official website of the original drug manufacturer, etc.) and are for reference only.

Precautions for use of Almirol in special populations

1. Elderly patients

There is currently no pharmacokinetic research data specifically for elderly patients. For elderly patients, it is especially important to carefully adjust the dosage of Amirol under the guidance of a doctor, and closely monitor its effects on the liver and kidneys, as well as possible adverse reactions.

2. Patients with hepatic and renal insufficiency

The safety and pharmacokinetics of Almero in patients with hepatic and renal insufficiency have not yet been clarified. Therefore, patients with hepatic insufficiency should use it with caution. If necessary, adjust the dosage or suspend use under the guidance of a doctor. Patients with renal insufficiency should also be used with caution and under close monitoring.

3. Pregnant and lactating women

Currently there is a lack of relevant clinical data to support the safety of use of Almiro in pregnant and lactating women. Therefore, it is not recommended for use by this group of people unless a doctor clearly judges that the benefits outweigh the risks.

4. Males and females with reproductive potential

It is not clear in the instructions.

5. Use in children

The safety and effectiveness of Amirol in children under 16 years of age have not been established, and its use is not recommended for patients in this age group.

Important Precautions of Almiro

1. Long-term use of Almiro may cause retinal pigment changes and even lead to pigmentary macular degeneration. Therefore, patients should undergo a detailed ophthalmological examination before starting treatment with Almirol and have regular reexaminations while taking the drug.

2. Almirol may increase the risk of bleeding. If patients plan to undergo surgery, they should inform the doctor in advance so that the drug withdrawal time can be reasonably arranged.

3. Tell your doctor immediately if you notice any unusual bleeding or bruising, black tarry stools, blood in the urine or stool, or pinpoint red spots on your skin.

4. Please be careful not to cut yourself when using sharp objects (such as safety razors or nail clippers).

5. Avoid participating in contact sports or other situations where bruises or injuries may occur.